Notice: Undefined index: OS in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/const.inc.php on line 64 Notice: Undefined variable: siters in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 2414 Notice: Undefined index: User in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/const.inc.php on line 108 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 3607 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 3612 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 70 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 74 Notice: Undefined index: User in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 158 Notice: Undefined index: SID in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 177 Notice: Undefined index: UID in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 179 Notice: Undefined variable: UserName in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 180 Notice: Undefined variable: Mobile in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 181 Notice: Undefined variable: Email in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 182 Notice: Undefined variable: Num in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 183 Notice: Undefined variable: keyword in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 184 Notice: Undefined index: ac in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 189 Notice: Undefined index: CHtml in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 191 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/common.php on line 201 Notice: Undefined index: t in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/info_view.php on line 40 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 3607 Notice: Undefined offset: 0 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 3612 Notice: Undefined variable: strimg in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 3612 Notice: Undefined offset: 1 in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 617 Notice: Undefined index: enseo in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/Include/function.inc.php on line 3076 Notice: Undefined variable: TPath in /usr/home/wh-as5ubll29rj6kxf8oxm/htdocs/pcen/info_view.php on line 125 Experimental drugs can improve the survival rate of pancreatic cancer patients-瞭望新时代网

Health

Experimental drugs can improve the survival rate of pancreatic cancer patients

2023-11-20   

Science and Technology Daily (Reporter Zhang Jiaxin) Researchers from Wilmot Cancer Research Institute of the University of Rochester Medical Center in the United States discovered an experimental drug NP137 that can prevent the migration of pancreatic tumors by understanding the genetic changes that occur during the migration process. This drug can treat pancreatic cancer that has spread to the liver. The relevant research is published in the new issue of Cell Reports. Why is pancreatic cancer fatal? Firstly, it spreads very early during development. In 85% of patients, cancer has already spread beyond the pancreas at the time of diagnosis. Secondly, when pancreatic cancer cells reach the liver, they will reprogram on the gene and become more powerful. The result is that newly implanted cancer cells in the liver have significantly different biological characteristics from primary pancreatic tumors and can resist standard treatment. The key gene Netrin-1 is related to pancreatic cancer, breast cancer and colon cancer. Researchers found for the first time that Netrin-1 can drive fatal gene changes when pancreatic cancer cells migrate to the liver. They also showed how Netrin-1 gene activates hepatic stellate cells related to liver fibrosis. In mouse studies, when researchers suppressed Netrin-1 with the anticancer drug NP137, the likelihood of cancer spread was reduced and cancer cell death was caused. Researchers suggest that in clinical trials, eligible patients may be required to take two cycles of NP137 before surgery, undergo surgical resection of the tumor, and then take more NP137 during chemotherapy for up to 6 months after surgery. (New News Agency)

Edit:GuoGuo Responsible editor:FangZhiYou

Source:people.cn

Special statement: if the pictures and texts reproduced or quoted on this site infringe your legitimate rights and interests, please contact this site, and this site will correct and delete them in time. For copyright issues and website cooperation, please contact through outlook new era email:lwxsd@liaowanghn.com

Recommended Reading Change it

Links